powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1396008918
Michael Toole
M.D.
Hematology-Oncology
Fort Wayne,
IN
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
83.5
Quality
70.0
Cost
75.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.36%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,796
Beneficiaries
—
Total drug cost
$11.8M
Distinct drugs
40
Brand share
48.8%
Top prescribed drugs
Lenalidomide
211 claims
Acyclovir
140 claims
Zanubrutinib
124 claims
Apixaban
120 claims
Hydroxyurea
110 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$410
Payment records
12
By payment type
Food and Beverage
$410
Top paying entities
Food and Beverage
$410
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
467
Unique beneficiaries
—
Total services
976
Distinct HCPCS
10
Medicare payment
$64K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 177 Hematology-Oncology providers in IN — above median (cohort median 1,010).
